908 Devices Acquires TRACE Analytics, Enabling On-line Bioanalytics

08.09.22 BOSTON–(BUSINESS WIRE)–908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announces that it has completed the acquisition of privately-held TRACE Analytics GmbH, based in Braunschweig, Germany, a provider of on-line analysis and sampling systems for biotech applications. 908 Devices expects the acquired technology to... Read more

Bio-Techne and 908 Devices Announce Joint Collaboration

MAY 04, 2021 MINNEAPOLIS and BOSTON, May 4, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) and 908 Devices (NASDAQ: MASS) today announced a joint collaboration to develop an extended workflow solution for protein characterization. Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and owner of the leading ProteinSimple... Read more

908 Devices launches the Rebel, the first at-line spent cell media analyzer for bioprocess labs Life Sciences

08.10.19 908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced the launch of their new bioprocess analyzer, the Rebel™. This first-of-its-kind, miniature CE-MS-based analyzer lets biopharma researchers accelerate process development cycles and maximize their bioreactor utilization by running media analysis at-line, anytime. The company is presenting the Rebel for the... Read more

908 Devices poised to modernize upstream bioprocess analytics with a grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

07.25.19 908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, announced it has been awarded a technical project grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). This award will fuel continued development of simple, at-line bioreactor process analytics – a collaboration between 908 Devices, MilliporeSigma, the University of North Carolina at Chapel... Read more

908 Devices Addresses Emerging Novichok Nerve Agent Threat, Expands Capabilities for MX908 Chemical Detection Device

Field Forensics 908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced the expansion of their MX908™ multi-mission trace chemical detection device capabilities to include Novichok agents, an emerging chemical warfare threat. The company is debuting this enhancement in the MX908 CW Hunter mission mode at the 2019 International Association of... Read more

908 Devices broadens the ZipChip platform, brings new capability to biotherapeutics researchers

BOSTON, June 3, 2019 — 908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced several advancements to their ZipChip® product line, which build upon its industry-leading biotherapeutic analysis capabilities in multiple critical application areas. These product and application expansions will be showcased at the 67th Annual ASMS Conference being held in... Read more

908 Devices Secures $17.5 Million in Growth Funding

04.29.19 908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced it has closed $17.5 million in a growth equity funding round.  This Series E funding brings the company’s total to $70M, making 908 Devices the most well-resourced upstart in the multibillion-dollar mass spectrometry market.  The round was led by Northpond... Read more

908 Devices’ High-Pressure Mass Spectrometry (HPMS) Technology to Power Next-Generation Advanced Chemical Threat Detector for U.S. Department of Defense

BOSTON, Jan. 9, 2019 /PRNewswire/ — 908 Devices Inc., a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, today announced they will provide their High-Pressure Mass Spectrometry™ (HPMS) technology platform to the next phase of the U.S. Department of Defense’s (DOD) new Aerosol and Vapor Chemical Agent Detector (AVCAD) program. The company and partner... Read more

Massachusetts Governor Charlie Baker tours new 908 Devices Boston Headquarters

12.20.18 908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, were honored today to host Massachusetts Governor Charlie Baker for a tour of their new corporate headquarters. Fueled by expanding R&D and increased manufacturing needs, 908 Devices relocated to the Pappas Commerce Center at the heart of Boston’s Seaport District in... Read more

908 Devices’ MX908 out-designs designer drugs

BOSTON, Oct. 23, 2018 /PRNewswire/ — 908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, today announced the addition of a novel predictive fentanyl classifier for their MX908 multi-mission trace chemical detection device. The company recently previewed this new capability with law enforcement at the International Association of Chiefs of Police... Read more